Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques.

L Carrivick1, S Rogers, J Clark

  • 1Advanced Computing Research Centre, University of Bristol, Bristol, UK.

Journal of the Royal Society, Interface
|July 20, 2006
PubMed
Summary

A new Bayesian analysis method, latent process decomposition, identified four distinct breast cancer subtypes. This approach offers better insights into patient stratification and clinical outcomes compared to traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation.

Public health·2023
Same author

"Oh! How Modern! And... Are You Ok with That?": Consensually Non-Monogamous People's Experiences When Accessing Sexual Health Care.

Journal of sex research·2023
Same author

Whole-genome sequencing to investigate transmission of SARS-CoV-2 in the acute healthcare setting: a systematic review.

The Journal of hospital infection·2023
Same author

Guillain-Barré Syndrome and Unilateral Optic Neuritis Following Vaccination for COVID-19: A Case Report and Literature Review.

Neuro-ophthalmology (Aeolus Press)·2022
Same author

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Cutaneous adverse drug reactions to fixed-dose combination treatments for TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Microarray data analysis is crucial for understanding breast cancer heterogeneity.
  • Existing methods like hierarchical cluster analysis have limitations in objective model selection and noise handling.

Purpose of the Study:

  • To apply a novel Bayesian data analysis technique, latent process decomposition, to breast cancer microarray datasets.
  • To compare the advantages of latent process decomposition over hierarchical cluster analysis for identifying distinct patient subgroups.

Main Methods:

  • Latent process decomposition, a Bayesian technique, was applied to four breast cancer microarray datasets.
  • This method allows for objective determination of the optimal number of clusters and penalizes over-complex models.

Related Experiment Videos

  • It utilizes a common latent space for explanatory variables for both samples and genes.

    • Main Results:

    • The analysis revealed four principal patient processes, each linked to a specific clinical outcome.
    • One identified process is indolent, characterized by under-expression of tumor growth-associated genes.
    • Another process involves over-expression of GRB7 and ERBB2, while the most aggressive process shows abnormal expression of transcription factors, including the FOX family.

    Conclusions:

    • Latent process decomposition provides clearer insights into breast cancer datasets, enabling more precise patient stratification.
    • This technique offers advantages in objective cluster assessment and model fitting compared to hierarchical clustering.
    • The identified subtypes highlight distinct molecular mechanisms and clinical trajectories in breast cancer.